Today: 8 June 2026
India Stock Market Today: Why Sensex Is Down 1,000 Points and Nifty Has Cracked 24,000
24 April 2026
2 mins read

India Stock Market Today: Why Sensex Is Down 1,000 Points and Nifty Has Cracked 24,000

Mumbai, April 24, 2026, 12:55 IST

Indian stocks slid sharply Friday. The Sensex dropped over 1,000 points, while the Nifty 50 broke under 23,900 midway through the session. Tech names took another hit, and rising oil prices helped flip a tentative start into widespread selling.

The drop dragged the market closer to a third loss in a row, threatening to break a two-week winning stretch for both main indexes. By early trade, the Nifty 50 slipped 0.66% to 24,013.75 and the BSE Sensex was off 0.76% at 77,074.63. Notably, every one of the 16 key sectors traded in the red.

Oil is trickier. Brent crude pushed up to around $106 a barrel, with worries over the Strait of Hormuz sharpening investor attention on India’s import costs, inflation, and corporate margins; India, heavily reliant on foreign oil, usually feels the pinch when crude prices climb.

J.P. Morgan has downgraded Indian equities to “neutral” from “overweight”, pointing to rich valuations and earnings headwinds tied to energy shocks following the Iran war. The bank lowered its Nifty 50 target for year-end by 10%, setting it at 27,000. Forecasts for FY2027 earnings were also pulled back across energy, consumer, auto, and financials. Reuters

Just a day prior, HSBC cut its rating on India to “underweight” from “neutral.” Herald van der Linde, who heads Asia-Pacific equity strategy at the bank, said India now appears “less attractive than its North East Asian peers” given today’s macro conditions, and he expects earnings downgrades ahead. Business Standard

The tech sector proved a drag. Infosys put its fiscal 2027 constant-currency revenue growth at just 1.5% to 3.5%—lower than the 2% to 4% analysts had penciled in. That constant-currency metric excludes currency fluctuations. According to Reuters, Tata Consultancy Services recorded its first annual revenue dip in over 20 years. HCLTech also flagged soft growth for the year.

Pareekh Jain, who leads IT research firm EIIR Trend, pointed out that investors had been hoping for stronger FY2027 growth, but Infosys and HCLTech failed to provide it. Infosys CEO Salil Parekh described the company’s AI services strategy as “gaining traction in the market,” though that progress wasn’t sufficient to make up for the disappointing guidance. Moneycontrol

Selling didn’t just hit the major IT stocks. The Nifty IT index slipped nearly 3%, with Tech Mahindra, Mphasis, Infosys, LTIMindtree, and Coforge all in the red. Pressure wasn’t confined to the big names—mid-cap and small-cap stocks took a hit too.

Currency woes are piling onto equity market strain. The rupee’s real effective exchange rate, which factors in inflation and trade, just dropped to its weakest level in over ten years—dragged lower by rising crude and steady foreign portfolio outflows. Chief Economic Adviser V. Anantha Nageswaran told Bloomberg News that, for long-term investors, the current valuation could be an “attractive entry point.” Reuters

Risks aren’t all pointed in one direction. A genuine thaw in the U.S.-Iran standoff could see crude prices slip and steady broader risk appetite. But if disruptions in the Hormuz corridor drag on, oil stays elevated, and pressure mounts on the rupee and foreign inflows. “De-escalation in violence, oil prices and volatility isn’t likely to be linear,” said Vishnu Varathan, Mizuho’s head of macro strategy for Asia-Pacific. Reuters

Stock Market Today

  • Indian Stock Market July 8: Cautious Start Amid Middle East Tensions
    June 8, 2026, 9:21 AM EDT. Indian stocks are poised for a cautious open on June 8, impacted by rising Middle East tensions and a global market selloff. The GIFT Nifty index fell over 1%, as Asian markets including South Korea and Japan declined sharply, signaling increased investor risk aversion. Higher crude oil prices and a rebound in gold indicate a shift towards defensive assets. Investors will watch key domestic developments in companies like TVS Motor, RailTel, KNR Constructions, Creative Newtech, Amber Enterprises, and Ixigo. Fundraising activities at Zee, ASM Technologies, and Gujarat Themis, along with regulatory issues at Yes Bank, 5Paisa, and Reliance Infrastructure, will also remain in focus.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
FTSE 100 Falls Today as Oil Surge and Trump Tariff Threat Shake London Stocks
Previous Story

FTSE 100 Falls Today as Oil Surge and Trump Tariff Threat Shake London Stocks

FirstEnergy Ohio Bills Could Rise Up To $5 A Month As May 22 Rate Filing Nears
Next Story

FirstEnergy Ohio Bills Could Rise Up To $5 A Month As May 22 Rate Filing Nears

Go toTop